Trangil, Erha T.

HRN: 22-11-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
10/23/2022
10/30/2022
TOPICAL
1%
BID
Burns
Waiting Final Action 
10/23/2022
CEFUROXIME 750MG (VIAL)
10/23/2022
10/30/2022
IV
250mg
Q8
Burn
Waiting Final Action 
10/28/2022
CEFTAZIDIME 1GM (VIAL)
10/28/2022
11/04/2022
IV
200mg
Q8h
Burns
Waiting Final Action 
10/29/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
10/29/2022
11/05/2022
TOPICAL
Apply Thinly
BID
Burn
Waiting Final Action 
10/31/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
10/31/2022
11/07/2022
IVTT
450mg
Q6h
Scald Burn
Waiting Final Action 
11/02/2022
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
11/02/2022
11/08/2022
TOPICAL
Ample Amount
Bid
Scald Burn 30%TBSA
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: